Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Gains from Sales and Divestitures (2010 - 2021)

Dentsply Sirona posted quarterly Gains from Sales and Divestitures of $1.5 million for Q4 2021, up 762.07% on a QoQ basis from $174000.0 in Q3 2011.

Dentsply Sirona (XRAY) has 3 years of Gains from Sales and Divestitures data on file, last reported at $1.5 million in Q4 2021.

  • For the quarter ending Q4 2021, Gains from Sales and Divestitures changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2021 stood at $1.5 million (changed N/A YoY), and the FY2021 full-year result was $1.5 million, changed N/A from the prior year.
  • Gains from Sales and Divestitures for Q4 2021 stood at $1.5 million, up from $174000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.5 million in Q4 2021 and bottomed at $1.5 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Dentsply Sirona 1.99 Bn 1.80 Bn 427.00 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 1.50 Mn
Dec 31, 2021 1.50 Mn
Sep 30, 2011 174,000.00
Sep 30, 2011 174,000.00
Jun 30, 2011 -174,000.00
Jun 30, 2011 -174,000.00
Mar 31, 2011 172,000.00
Mar 31, 2011 172,000.00
Sep 30, 2010 -207,000.00
Sep 30, 2010 -207,000.00
Jun 30, 2010 -200,000.00
Jun 30, 2010 -200,000.00